CHELMSFORD, Mass., January 12, 2026--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that the LifeVest® wearable cardioverter ...
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that the LifeVest® wearable cardioverter defibrillator (WCD) saved 143 patients between ...
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that the LifeVest® wearable cardioverter defibrillator ...
ZOLL also pioneered the use of artificial intelligence in WCDs, introducing an AI-enhanced algorithm in 2018 that reduced false alarms to a median of zero at 90 days.³ The latest generation LifeVest ...
CHELMSFORD, Mass. & TOKYO, January 08, 2026--(BUSINESS WIRE)--Asahi Kasei announced that ZOLL ® Medical, an Asahi Kasei company, has launched the next-generation LifeVest ® wearable cardioverter ...
CHELMSFORD, Mass. & TOKYO--(BUSINESS WIRE)--Asahi Kasei announced that ZOLL ® Medical, an Asahi Kasei company, has launched the next-generation LifeVest ® wearable cardioverter defibrillator (WCD) in ...
ZOLL also pioneered the use of artificial intelligence in WCDs, introducing an AI-enhanced algorithm in 2018 that reduced false alarms to a median of zero at 90 days.³ The latest generation LifeVest ...
Asahi Kasei announced that ZOLL ® Medical, an Asahi Kasei company, has launched the next-generation LifeVest ® wearable cardioverter defibrillator (WCD) in the U.S., and completed the U.S. rollout of ...
Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today provides a business update highlighting the Company's recent achievements in strengthening its product franchise and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results